Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552759 · ClinicalTrials.gov registry record · NA
Appetite Hormones in Binge Eating Disorder
A NA study of Binge-Eating Disorder, sponsored by New York Obesity and Nutrition Research Center.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
- 1
- Study location
NCT01552759: Completed NA study of Binge-Eating Disorder, sponsored by New York Obesity and Nutrition Research Center.
NCT01552759 is a NA study of Binge-Eating Disorder that has completed, run by New York Obesity and Nutrition Research Center. The registered enrollment target is 96 participants, below the 1,141-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01552759, a NA study of Binge-Eating Disorder, has completed, sponsored by New York Obesity and Nutrition Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
- 1
- Study location
Study Summary
This study investigates the hormones that the body produces in response to food intake and in response to stress, and the way that stress influences food intake. In particular, it compares the hormone levels and food intake of people with and without binge eating disorder. In order to find out how these appetite- and stress-related hormones are linked to brain activity, the study also includes an fMRI scan, a non-invasive procedure that looks at which regions of the brain are most active during a food-related scenario.
Primary Outcome
Blood and saliva concentrations of hormones influencing appetite will be measured at systematic intervals (-15, 0, 10, 30, 60, 90, 120 min) before and after the morning fixed meal at 10.00 and the evening fixed meal at 17.00. Appetite will additionally be rated at each assessment point. This will be followed by a cold pressor test, and then 30 min later by an ad libitum meal 30 min later, with blood and saliva measurements taken before and after completion of the meal.
Conditions Studied
Interventions
- BEHAVIORAL Cold pressor test
- PROCEDURE Postprandial responses
- BEHAVIORAL Test meal
Study Locations (1)
New York
- St. Luke's Hospital - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2007-05 |
| Est. Completion | 2012-01 |
| Phase | NA |
What the finished NCT01552759 record still lists
NCT01552759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,141-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Binge-Eating Disorder appearing as the primary indexed condition, and to 3 interventions - of which Cold pressor test is the first listed.
NCT01552759 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01552759 about?
NCT01552759 is a clinical study titled "Appetite Hormones in Binge Eating Disorder". This study investigates the hormones that the body produces in response to food intake and in response to stress, and the way that stress influences food intake. In particular, it compares the hormone levels and food intake of people with and without binge eating disorder. In order to find out how t...
What is the current status of trial NCT01552759?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2007-05. Estimated completion is 2012-01.
What conditions does trial NCT01552759 study?
This clinical trial studies the following conditions: Binge-Eating Disorder.
What interventions are being tested in trial NCT01552759?
The interventions under investigation include: Cold pressor test (BEHAVIORAL), Postprandial responses (PROCEDURE), Test meal (BEHAVIORAL).
Who is sponsoring clinical trial NCT01552759?
This trial is sponsored by New York Obesity and Nutrition Research Center, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01552759 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01552759's enrollment target sits among peer trials
96 16th of 37 higher than 21 of 37 other Binge-Eating Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Binge-Eating Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia